All entries for: OsteoCat Therapeutics AB

November 25, 2025

OsteoCat Therapeutics AB

Orphan Drug Designation

FDA orphan drug designation: treatment of osteogenesis imperfecta

Disease Area: Rare Diseases
Scroll to Top